Module 7 Vaccines PDF

\-\-- \*\*Vaccines\*\* 1. \*\*Meningococcal Vaccine\*\* Routine immunization of adolescent \- \*\*Classification\*\*: Inactivated vaccine \- \*\*Action\*\*: Stimulates immunity against Neisseria meningitidis. \- \*\*Uses\*\*: Prevention of meningitis and meningococcal disease. \- \*\*Adv...

\-\-- \*\*Vaccines\*\* 1. \*\*Meningococcal Vaccine\*\* Routine immunization of adolescent \- \*\*Classification\*\*: Inactivated vaccine \- \*\*Action\*\*: Stimulates immunity against Neisseria meningitidis. \- \*\*Uses\*\*: Prevention of meningitis and meningococcal disease. \- \*\*Adverse Reactions\*\*: Pain at injection site, fever, headache, fatigue. \- \*\*Contraindications/Precautions\*\*: Hypersensitivity to components; defer in acute illness. \- \*\*Interactions\*\*: Immunosuppressants may reduce efficacy. \#\#\#\# 2. \*\*Meningococcal B Vaccine\*\* \- \*\*Classification\*\*: Recombinant vaccine \- \*\*Action\*\*: Targets serogroup B Neisseria meningitidis. \- \*\*Uses\*\*: Prevention of meningococcal group B infection. \- \*\*Adverse Reactions\*\*: Injection site reactions, fatigue, fever. \- \*\*Contraindications/Precautions\*\*: Same as above. \- \*\*Interactions\*\*: Same as above. \#\#\#\# 3. \*\*Pneumococcal Vaccine\*\* \- \*\*Classification\*\*: Polysaccharide or conjugate vaccine \- \*\*Action\*\*: Induces immunity against Streptococcus pneumoniae. \- \*\*Uses\*\*: Prevention of pneumonia, meningitis, and bacteremia. \- \*\*Adverse Reactions\*\*: Local reactions, fever, malaise. \- \*\*Contraindications/Precautions\*\*: Hypersensitivity; caution in immunocompromised patients. \- \*\*Interactions\*\*: Reduced efficacy with immunosuppressants. \#\#\#\# 4. \*\*Measles Vaccine\*\* \- \*\*Classification\*\*: Live attenuated vaccine \- \*\*Action\*\*: Provides immunity to measles virus. \- \*\*Uses\*\*: Prevention of measles. \- \*\*Adverse Reactions\*\*: Fever, rash, mild lymphadenopathy. \- \*\*Contraindications/Precautions\*\*: Pregnancy, severe immunodeficiency, acute illness. \- \*\*Interactions\*\*: Immune globulins may interfere with efficacy. \#\#\#\# 5. \*\*Human Papillomavirus (HPV) Vaccine\*\* \- \*\*Classification\*\*: Recombinant vaccine \- \*\*Action\*\*: Prevents HPV infections and associated conditions like cervical cancer. \- \*\*Uses\*\*: Prevention of HPV-related cancers and genital warts. \- \*\*Adverse Reactions\*\*: Injection site pain, headache, fever. \- \*\*Contraindications/Precautions\*\*: Hypersensitivity to components. \- \*\*Interactions\*\*: None significant. \#\#\#\# 6. \*\*Varicella Vaccine\*\* \- \*\*Classification\*\*: Live attenuated vaccine \- \*\*Action\*\*: Induces immunity against varicella-zoster virus. \- \*\*Uses\*\*: Prevention of chickenpox. \- \*\*Adverse Reactions\*\*: Rash, fever, injection site reactions. \- \*\*Contraindications/Precautions\*\*: Pregnancy, severe immunodeficiency. \- \*\*Interactions\*\*: Avoid salicylates for 6 weeks post-vaccine. \#\#\#\# 7. \*\*Zoster Vaccine\*\* \- \*\*Classification\*\*: Recombinant or live vaccine \- \*\*Action\*\*: Reduces the risk of herpes zoster (shingles). \- \*\*Uses\*\*: Prevention of shingles in older adults. \- \*\*Adverse Reactions\*\*: Injection site pain, fatigue, headache. \- \*\*Contraindications/Precautions\*\*: Severe immunocompromise (live vaccine). \- \*\*Interactions\*\*: None significant. \#\#\#\# 8. \*\*Rabies Vaccine\*\* \- \*\*Classification\*\*: Inactivated vaccine \- \*\*Action\*\*: Prevents rabies infection by stimulating antibody production. \- \*\*Uses\*\*: Pre- and post-exposure prophylaxis. \- \*\*Adverse Reactions\*\*: Pain, fever, malaise. \- \*\*Contraindications/Precautions\*\*: Hypersensitivity to components. \- \*\*Interactions\*\*: Immune globulins may affect response. \#\#\#\# 9. \*\*Diphtheria, Tetanus, Pertussis (DTaP/Tdap)\*\* \- \*\*Classification\*\*: Inactivated bacterial toxoid and subunit vaccine \- \*\*Action\*\*: Immunity against diphtheria, tetanus, and pertussis. \- \*\*Uses\*\*: Routine childhood immunization and booster for adults. \- \*\*Adverse Reactions\*\*: Injection site reactions, fever, irritability. \- \*\*Contraindications/Precautions\*\*: History of encephalopathy with pertussis-containing vaccine. \- \*\*Interactions\*\*: None significant. \#\#\#\# 10. \*\*Rh Immune Globulin (RIG, IGIV)\*\* \- \*\*Classification\*\*: Immune globulin \- \*\*Action\*\*: Prevents Rh sensitization in Rh-negative individuals. \- \*\*Uses\*\*: Prevents hemolytic disease of the newborn. \- \*\*Adverse Reactions\*\*: Local reactions, fever. uritcaria \- \*\*Contraindications/Precautions\*\*: Hypersensitivity to immunoglobulin. \- \*\*Interactions\*\*: Live vaccines may be less effective. \#\#\#\# 11. \*\*Tetanus Toxoid\*\* \- \*\*Classification\*\*: Inactivated bacterial toxoid \- \*\*Action\*\*: Induces immunity against tetanus toxin. \- \*\*Uses\*\*: Prevention of tetanus. \- \*\*Adverse Reactions\*\*: Injection site pain, fever. \- \*\*Contraindications/Precautions\*\*: Hypersensitivity to toxoid. \- \*\*Interactions\*\*: None significant. \#\#\#\# 12. \*\*Antivenin\*\* \- \*\*Classification\*\*: Antitoxin \- \*\*Action\*\*: Neutralizes venom from specific bites/stings. \- \*\*Uses\*\*: Treatment of envenomation (e.g., snakebite, spider bite). \- \*\*Adverse Reactions\*\*: Hypersensitivity, serum sickness. \- \*\*Contraindications/Precautions\*\*: Hypersensitivity to equine or ovine proteins. \- \*\*Interactions\*\*: None significant. \-\-- \#\#\# \*\*Medications\*\* \#\#\#\# 1. \*\*Filgrastim\*\* \- \*\*Classification\*\*: Colony-stimulating factor \- \*\*Action\*\*: Stimulates neutrophil production. \- \*\*Uses\*\*: Neutropenia in chemotherapy or bone marrow transplantation. \- \*\*Adverse Reactions\*\*: Bone pain, fever, injection site pain. \- \*\*Contraindications/Precautions\*\*: Hypersensitivity to E. coli-derived proteins. \- \*\*Interactions\*\*: None significant. \#\#\#\# 2. \*\*Folic Acid\*\* \- \*\*Classification\*\*: Vitamin \- \*\*Action\*\*: Essential for DNA synthesis and red blood cell production. \- \*\*Uses\*\*: Megaloblastic anemia, pregnancy supplementation. \- \*\*Adverse Reactions\*\*: Rare; may include rash or bronchospasm. \- \*\*Contraindications/Precautions\*\*: None significant. \- \*\*Interactions\*\*: Anticonvulsants may reduce efficacy. \#\#\#\# 3. \*\*Leucovorin\*\* \- \*\*Classification\*\*: Folic acid derivative \- \*\*Action\*\*: Protects normal cells from methotrexate toxicity. \- \*\*Uses\*\*: Methotrexate rescue therapy, folate deficiency anemia. \- \*\*Adverse Reactions\*\*: Allergic reactions, rash. \- \*\*Contraindications/Precautions\*\*: Pernicious anemia. \- \*\*Interactions\*\*: Reduces the effects of methotrexate. \#\#\#\# 4. \*\*Epoetin Alfa\*\* \- \*\*Classification\*\*: Erythropoiesis-stimulating agent \- \*\*Action\*\*: Stimulates red blood cell production. \- \*\*Uses\*\*: Anemia from chronic kidney disease or chemotherapy. \- \*\*Adverse Reactions\*\*: Hypertension, thrombosis. \- \*\*Contraindications/Precautions\*\*: Uncontrolled hypertension. \- \*\*Interactions\*\*: None significant. \#\#\#\# 5. \*\*Cyanocobalamin (Vitamin B12)\*\* \- \*\*Classification\*\*: Vitamin \- \*\*Action\*\*: Essential for DNA synthesis and red blood cell maturation. \- \*\*Uses\*\*: Pernicious anemia, B12 deficiency. \- \*\*Adverse Reactions\*\*: Rare; may include injection site reactions. \- \*\*Contraindications/Precautions\*\*: Optic nerve atrophy. \- \*\*Interactions\*\*: Chloramphenicol may interfere with efficacy.